Printer Friendly

Response to: Comment on "Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography".

We thank Drs. Xue and Cai for their interest in our study and we appreciate their comments regarding its design [1, 2]. They identify an important factor in the interpretation of transient elastography (TE) results, namely, the potential for falsely elevated values in the context of raised alanine aminotransferase (ALT).

As referenced in our paper, recent data suggest that TE values may be 1.3-3 times higher in the setting of acute liver inflammation and moderately elevated ALT [3]. In the 2012 study by Tapper et al., increased levels of ALT correlated with liver stiffness among hepatitis C patients with METAVIR scores 0-2. A recent study of pediatric patients with a variety of liver diseases similarly found that the correlation between ALT and TE result was stronger among those with inflammatory diagnoses and F0/F1 fibrosis [4].

The patients included in the studies referenced by Drs. Xue and Cai all had acute or chronic hepatitis from inflammatory conditions, namely, infectious (HAV, HBV, and HCV), toxic, or autoimmune diagnoses. This is in important contrast to our cohort of Fontan patients. Histologic studies of liver biopsies after Fontan demonstrate varying degrees of portal and sinusoidal fibrosis, but inflammatory changes are quite rare [5, 6].

In our study, although the ALT levels among Fontan patients were significantly higher than those in the healthy controls, the absolute levels of ALT were within the normal reference ranges provided by the respective laboratories (12.0-54.0 U/L). This is also in contrast to the abovementioned studies, where a majority of patients had ALT values that were elevated, in some cases considerably so.

In summary, while it is important to interpret TE results thoughtfully in the context of hepatic inflammation and ALT elevation, we feel that this factor likely does not significantly contribute to the elevated TE values among our Fontan patients. TE values in our Fontan cohort likely represent the contributions of hepatic congestion and possible fibrosis. We agree, however, that further prospective studies involving TE are necessary to determine its optimal utility in this patient population.

http://dx.doi.org/10.1155/2017/4217878

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

[1] X. Xue and S. Cai, "Comment on 'Assessment of liver stiffness in pediatric Fontan patients using transient elastography'," Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 9343960, 2 pages, 2016.

[2] B. Chen, R. A. Schreiber, D. G. Human et al., "Assessment of liver stiffness in pediatric Fontan patients using transient elastography," Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 7125193, 7 pages, 2016.

[3] E. B. Tapper, E. B. Cohen, K. Patel et al., "Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection," Clinical Gastroenterology and Hepatology, vol. 10, no. 8, pp. 932-937, 2012.

[4] A. Raizner, N. Shillingford, P. D. Mitchell et al., "Hepatic inflammation may influence liver stiffness measurements by transient elastography in children and young adults," Journal of Pediatric Gastroenterology and Nutrition, 2016.

[5] C. H. Kiesewetter, N. Sheron, J. J. Vettukattill et al., "Hepatic changes in the failing Fontan circulation," Heart, vol. 93, no. 5, pp. 579-584, 2007

[6] T. J. Kendall, B. Stedman, N. Hacking et al., "Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study," Journal of Clinical Pathology, vol. 61, pp. 504-508, 2008.

Becky Chen, (1) Richard A. Schreiber, (2,3) Derek G. Human, (3,4) James E. Potts, (3,4) and Orlee R. Guttman (2,3)

(1) Department of Pediatrics, Children's Hospital of Western Ontario, London, ON, Canada

(2) Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, Vancouver, BC, Canada

(3) University of British Columbia, Vancouver, BC, Canada

(4) Childrens Heart Centre, British Columbia Children's Hospital, Vancouver, BC, Canada

Correspondence should be addressed to Orlee R. Guttman; oguttman@cw.bc.ca

Received 11 October 2016; Accepted 15 October 2016; Published 8 February 2017

Academic Editor: Eric M. Yoshida
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Chen, Becky; Schreiber, Richard A.; Human, Derek G.; Potts, James E.; Guttman, Orlee R.
Publication:Canadian Journal of Gastroenterology and Hepatology
Article Type:Letter to the editor
Date:Jan 1, 2017
Words:667
Previous Article:Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp".
Next Article:Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters